Home Cardax Pharma

Cardax Pharma

In operation
Post-IPO Round
Small Molecule Therapy Developer
Basic
Enterprise Profile

Basic Information

Cardax Pharmaceuticals Inc. is developing patented small molecule therapies for major causative factors such as oxidative stress and inflammation, including dyslipidemia, metabolic diseases, arthritis, cardiovascular diseases, hepatitis, and macular degeneration.
Cardax Pharmaceuticals Inc.
Honolulu,Hawaii,United States of America
less than 15 people
January 01, 2006
info@cardaxpharma.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Biotechnology
Concept
Cardiology Department Disease Treatment Cardiovascular Disease Metabolic Diseases
Application Scenarios
Biologics Innovative Drugs